软通道微创术治疗临界量高血压基底节区出血的疗效观察

目的探讨应用软通道微创术治疗临界量（25-35ml）高血压基底节区出血的临床效果。方法2011年1月至2014年1月我院收治的58例符合研究标准的临界量高血压基底节区出血患者,随机分为软通道微创治疗组（n=28）和内科保守治疗组（n=30）。对比分析两组患者住院期间并发症发生率、再出血率、血肿消失时间、住院时间和近期（治疗后2周）及远期（治疗后3个月）疗效（包括GCS、GOS、日常生活能力Barthel指数、死亡率等指标）。结果远期疗效在内科保守治疗组与软通道微创治疗组无明显差异（P〉0.05）;但在降低住院期间并发症发生率、缩短血肿清除时间、缩短住院时间及近期疗效方面,软通道微创治疗组明显优于内科保守治疗组（P〈0.05）。结论软通道微创术清除血肿是临界量高血压基底节区出血的一种良好治疗策略。

Observation of curative effect of microinvasive treatment with soft-tube technique for hypertensive hemorrhage in basal ganglia region with a critical volume

Objective To investigate the curative effect of microinvasive treatment with soft-tube technique for hypertensive hemorrhage in basal ganglia region with a critical volume of25 to 35ml.Methods 58 patients of hypertensive hemorrhage in basal ganglia region with a critical volume were randomly divided into microinvasive treatment with soft-tube technique group（n=28）and conservative treatment group（n=30）.The rates of the complications and rebleeding,hematoma disappearing time,hospital stays and the curative effects including GCS,GOS,Barthel index（BI）of activities of daily living and mortality 2weeks and 3months after the treatment were analyzed.Results The long-term efficacy assessment after follow-up for three months after the treatment indicated no significant difference among conservative treatment and microinvasive treatment（P〉0.05）.However,microinvasive treatment showed obvious advantages of fewer complications,faster removal of hematoma,shorter hospitalization and better short-term efficacy（P〈0.05）.Conclusion The microinvasive treatment with soft-tube technique to drain the hematoma is a good way in treating hypertensive hemorrhage of basal ganglia region.